Mineralys Therapeutics, Inc. MLYS Debt Securities, Current
Debt Securities, Current at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesCurrent.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s debt securities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s debt securities, current?
- Mineralys Therapeutics, Inc. (MLYS) reported debt securities, current of $533.28M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s debt securities, current changed year-over-year?
- Mineralys Therapeutics, Inc.'s debt securities, current increased by 199.6% year-over-year, from $178.02M to $533.28M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s debt securities, current?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s debt securities, current has grown at a 60.7% compound annual growth rate (CAGR), from $187.26M to $483.71M.
- What does debt securities, current mean?
- This represents the portion of debt securities held by the company that are expected to be realized or settled within one year. It reflects the company's short-term liquidity position and its strategy for managing idle cash through interest-bearing instruments.